Fundraising Overview - The company raised a total of RMB 364.71 million through a private placement in 2021, with a net amount of RMB 362.46 million after deducting various fees [1][6][18] - In 2023, the company issued 8,415,450 shares at RMB 32.88 per share, raising RMB 276.70 million, with a net amount of RMB 266.45 million after fees [4][6][18] Fund Allocation and Usage - As of March 31, 2025, the company had RMB 362.06 million in its fundraising account, with RMB 19.34 million allocated for temporary working capital [2][3][5] - The company has used RMB 102.44 million for working capital and has a remaining balance of RMB 17.32 million from the 2021 fundraising [14][18] Project Updates - The probe station R&D and industrialization project has been delayed, with the expected completion date extended to December 31, 2025, and the budget reduced to RMB 210.27 million [8][9][10] - The company has decided to redirect RMB 50 million from the probe station project to the high-end smart manufacturing base project, which aims to enhance production capacity [8][9][10] Financial Performance - The probe station project has reported a cumulative loss of RMB 7.10 million as of March 31, 2025, falling short of the expected profit of RMB 44.68 million [14][19] - The company has not made any performance commitments for the acquisition of Changyi Technology, which is now fully owned [16][19] Idle Funds Management - The company has utilized idle funds for temporary working capital, with a total of RMB 69.92 million used as of March 31, 2025, and all funds returned to the special account within the stipulated time [18][19]

Core Viewpoint - The company has not faced any penalties from regulatory authorities in the last five years and has taken corrective measures in response to previous regulatory communications [1][5]. Group 1: Regulatory Actions - In the last five years, the company received one inquiry letter from the Shenzhen Stock Exchange and one warning letter from the Zhejiang Securities Regulatory Bureau [2][3]. - The inquiry letter required the company to clarify the basis and rationale for its 2020 profit distribution plan, assess potential risks related to stock price manipulation, and ensure compliance with information disclosure obligations [2]. - The warning letter highlighted issues such as premature revenue recognition in 2022, improper management of raised funds, and inadequate internal controls over sales [3][4]. Group 2: Corrective Measures - The company took the issues raised in the warning letter seriously and implemented corrective actions, submitting a written report to the Zhejiang Securities Regulatory Bureau [5]. - The company has ensured that there were no penalties imposed by the regulatory authorities for the matters addressed in the warning letter [5].

Core Viewpoint - The company plans to issue shares to specific investors, which may dilute immediate returns, and has outlined measures to compensate for this dilution while ensuring the protection of minority investors' rights [1][4]. Financial Impact Analysis - The company estimates that the total share capital will increase from 62,514.47 million shares to 81,379.28 million shares post-issuance, with a maximum of 188,648,115 shares to be issued [2][3]. - The total amount of funds raised is projected to be 313,203.05 million yuan [2]. - The company has provided three scenarios for net profit growth in 2025 compared to 2024: no growth, a 15% increase, and a 30% increase, affecting earnings per share and return on equity [3]. Use of Proceeds - The funds raised will be allocated to a semiconductor equipment R&D project and to supplement working capital, which aligns with the company's core business and long-term strategic goals [5][6]. - The semiconductor equipment R&D project aims to enhance product technology depth and support domestic demand, contributing to market share growth and improved financial performance [5]. Measures to Mitigate Dilution - The company has established a management framework for the use of raised funds, ensuring compliance with relevant laws and regulations to enhance fund utilization efficiency [6][7]. - A commitment to maintain shareholder rights and improve governance structures has been made, ensuring that the board acts in the best interests of all shareholders [7][8]. Commitments from Management - The board of directors and senior management have pledged to uphold their responsibilities and ensure the effective implementation of measures to mitigate the impact of share dilution on immediate returns [8][9]. - The controlling shareholders have also committed to maintaining the company's independence and not interfering with its management, ensuring that the interests of minority shareholders are protected [9].

Core Viewpoint - Changchuan Technology plans to issue A-shares to specific investors, which may significantly reduce the shareholding ratio of its actual controllers, Zhao Yi and Xu Xin, from 28.48% to 18.10% after the issuance and share transfer [1][9]. Group 1: Fundraising and Investment Plans - The company intends to invest approximately 22 billion yuan in semiconductor equipment research and development, with a total project investment of about 38 billion yuan [2][4]. - The funds will be used to purchase R&D equipment, hire relevant personnel, and develop testing machines and automatic optical inspection (AOI) devices [4]. - An additional 9.4 billion yuan will be allocated to supplement working capital, addressing the increasing financial needs in talent, management, technology, and R&D as the business scales [5]. Group 2: Shareholding Structure and Control - Zhao Yi holds 22.51% of the shares, while Xu Xin controls 5.97% through a partnership, totaling 28.48% before the share transfer [6]. - Following the transfer of approximately 31.16 million shares to a private fund, their combined control will decrease to 23.53%, and potentially to 18.10% after the new share issuance [7][9]. - Despite the reduction in shareholding percentage, Zhao Yi and Xu Xin will remain the actual controllers of the company [11].

Group 1 - The company, Changchuan Technology, announced a plan to issue shares to specific investors to raise a total of 3.132 billion yuan [1] - The raised funds will be allocated for the "semiconductor equipment R&D project" and to supplement working capital [1]

向特定对象发行股票预案的披露事项不代表审批机关对本次向特定对象发 行股票相关事项的实质性判断、确认或批准，预案所述本次向特定对象发行股票 相关事项的生效和完成尚需公司股东大会审议通过及有关监管机构的审批，存在 一定的不确定性。敬请广大投资者注意投资风险。 杭州长川科技股份有限公司 证券代码：300604 证券简称：长川科技 公告编号：2025-038 董 事 会 2025年6月25日 杭州长川科技股份有限公司 关于向特定对象发行股票预案披露的提示性公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 杭州长川科技股份有限公司（以下简称"公司"）于 2025 年 6 月 24 日召开 第四届董事会第十次会议、第四届监事会第十次会议，审议通过了关于公司向特 定对象发行股票的相关议案。公司于 2025 年 6 月 25 日在中国证监会指定的创业 板信息披露网站巨潮资讯网（http://www.cninfo.com.cn）上披露了《2025 年度向 特定对象发行 A 股股票预案》及相关文件，敬请投资者注意查阅。 ...

证券代码：300604 证券简称：长川科技 杭州长川科技股份有限公司 Hangzhou Changchuan Technology Co.,Ltd （注册地址：浙江省杭州市滨江区聚才路 410 号） 2025 年度向特定对象发行 A 股股票预案 2025 年 6 月 杭州长川科技股份有限公司 向特定对象发行股票预案 公司声明 公司及董事会全体成员保证本预案内容真实、准确、完整，并确认不存在虚 假记载、误导性陈述或重大遗漏，并对其内容的真实性、准确性、完整性和及时 性承担个别和连带的法律责任。 本预案按照《中华人民共和国证券法》《上市公司证券发行注册管理办法》 等规定编制。 本次向特定对象发行股票完成后，公司经营与收益的变化，由公司自行负责； 因本次向特定对象发行股票引致的投资风险，由投资者自行负责。 本预案是公司董事会对本次向特定对象发行股票事项的说明，任何与之相反 的声明均属不实陈述。 投资者如有任何疑问，应咨询自己的股票经纪人、律师、专业会计师或其他 专业顾问。 本预案所述事项并不代表审批机关对于本次向特定对象发行股票相关事项 的实质性判断、确认、批准或注册。本预案所述本次向特定对象发行股票相关事 项的生 ...

证券代码：300604 证券简称：长川科技 杭州长川科技股份有限公司 2025 年度向特定对象发行股票方案的论证 分析报告 二〇二五年六月 杭州长川科技股份有限公司 向特定对象发行股票方案的论证分析报告 杭州长川科技股份有限公司（以下简称"长川科技"或"公司"）为满足公 司业务发展的资金需求，增强公司核心竞争力和资本实力，提升盈利能力，促进 公司长远发展，根据《中华人民共和国公司法》《中华人民共和国证券法》《上市 公司证券发行注册管理办法》（以下简称"《注册管理办法》"）等有关法律、法规 和规范性文件的规定，拟向特定对象发行股票，募集资金总额不超过 313,203.05 万元（含本数），在扣除发行费用后的募集资金净额将用于"半导体设备研发项 目"和补充流动资金。 一、本次向特定对象发行的背景和目的 （一）本次向特定对象发行股票的背景 1、国家政策支持半导体行业发展 集成电路产业是信息技术产业发展的核心基础，是支撑经济社会发展和保障 国家安全的战略性、基础性和先导性产业，其发展水平代表着一个国家的综合实 力和保障国家安全的能力。我国集成电路产业起步较晚，发展相对落后，但在国 家政策和市场发展的推动下，发展速度明 ...

杭州长川科技股份有限公司全体股东： 我们审核了后附的杭州长川科技股份有限公司（以下简称长川科技公司）管 理层编制的最近三年及一期非经常性损益明细表（2022－2024 年度以及 2025 年 1－3 月）及其附注（以下简称非经常性损益明细表）。 一、对报告使用者和使用目的的限定 本鉴证报告仅供长川科技公司向特定对象发行股票时使用，不得用作任何其 他目的。我们同意本鉴证报告作为长川科技公司向特定对象发行股票的必备文件， 随同其他申报材料一起上报。 目 录 | 一、最近三年及一期非经常性损益的鉴证报告……………………第 1—2 | | | 页 | | --- | --- | --- | --- | | 二、最近三年及一期非经常性损益明细……………………………… 第 | | 3 | 页 | | 三、最近三年及一期非经常性损益明细表附注……………………第 4—8 | | | 页 | | 四、附件…………………………………………………………… 9—13 | 第 | | 页 | | （一）本所营业执照复印件……………………………………… 第 | | 9 | 页 | | （二）本所执业证书复印件…………………………………… ...

杭州长川科技股份有限公司 前次募集资金使用情况报告 根据中国证券监督管理委员会《监管规则适用指引——发行类第 7 号》的规定，将本公 司截至 2025 年 3 月 31 日的前次募集资金使用情况报告如下。 根据中国证券监督管理委员会《关于同意杭州长川科技股份有限公司向特定对象发行股 票注册的批复》（证监许可〔2021〕516 号），本公司由主承销商华泰联合证券有限责任公 司（以下简称华泰联合证券）采用代销方式，向特定对象发行人民币普通股（A 股）股票 8,126,775 股，发行价为每股人民币 45.75 元，共计募集资金 37,180.00 万元，坐扣承销和 保荐费用 709.39 万元后的募集资金为 36,470.60 万元，由主承销商华泰联合证券于 2021 年 8 月 2 日汇入本公司募集资金监管账户。本次募集资金扣除承销及保荐费 669.24 万元（不 含税）后的金额为 36,510.76 万元，另减除上网发行费、申报会计师费、律师费、法定信息 披露等与发行权益性证券直接相关的新增外部费用 264.92 万元（不含税）后，公司本次募 集资金净额为 36,245.84 万元。上述募集资金到位情况业经天 ...